Siegel R, Ma J, Zou Z, et al. Cancer statistics. CA Cancer J Clin. 2014;64:9–29.
Chen W, Zheng R, Zeng H, et al. Annual report on status of cancer in China, 2011. Chin J Cancer Res. 2015;27:2.
Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136:629–41.
Nakaqawa S, Kageyama Y. Nuclear lncRNAs as epigenetic regulators-beyond skepticism. Biochim Biophys Acta. 2014;1839(3):215–22.
Koziol MJ, Rinn JL. RNA traffic control of chromatin complexes. Curr Opin Genet Dev. 2010;20:142–8.
Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014;15:7–21.
Kallen AN, Zhou XB, Xu J, et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell. 2013;52:101–12.
Brannan CI, Dees EC, Ingram RS, et al. The product of the H19 gene may function as an RNA. Mol Cell Biol. 1990;10(1):28–36.
Keniry A, Oxley D, Monnier P, et al. The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell Biol. 2012;14:659–65.
Wang HT, Gao Y, Zhao YX, et al. PARP-1 rs3219073 polymorphism may contribute to susceptibility to lung cancer. Genet Test Mol Biomarkers. 2014;18(11):736–40.
Adamec C. Example of the use of the nonparametric test. Test χ2 for comparison of 2 independent examples. Cesk Zdrav. 1964;12:613–9.
Guedj M, Nuel G, Prum B. A note on allelic tests in case-control association studies. Ann Hum Genet. 2008;72:407–9.
Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955;19:251–3.
Pauli A, Valen E, Lin MF, et al. Systematic identification of long noncoding RNAs expressed during zebrafish embryogenesis. Genome Res. 2012;22(3):577–91.
Swiezewski S, Liu F, Magusin A, et al. Cold-induced silencing by long antisense transcripts of an Arabidopsis Polycomb target. Nature. 2009;462(7274):799–802.
Houseley J, Rubbi L, Grunstein M, et al. A ncRNA modulates histone modification and mRNA induction in the yeast GAL gene cluster. Mol Cell. 2008;32(5):685–95.
Reeves MB, Davies AA, McSharry BP, et al. Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death. Science. 2007;316(5829):1345–8.
Cesana M, Cacchiarelli D, Legnini I, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011;147:358–69.
Guffanti A, Iacono M, Pelucchi P, et al. A transcriptional sketch of a primary human breast cancer by 454 deep sequencing. BMC. Genomics. 2009;10:163.
Khaitan D, Dinger ME, Mazar J, et al. Themelanoma-upregulated long noncoding RNASPRY4-IT1 modulates apoptosis and invasion. Cancer Res. 2011;71:3852–62.
Qiu M, Xu Y, Yang X, et al. Ccat2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer. Tumor Biol. 2014;35:5375–80.
Nie FQ, Sun M, Yang JS, et al. Long noncoding RNA ANRIL promotes non–small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer Ther. 2015;14:268–77.
Liu Y, Pan S, Liu L, et al. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One. 2012;7:e35145.
Guo W, Dong Z, Bai Y, et al. Associations between polymorphisms of hotair and risk of gastric cardia adenocarcinoma in a population of North China. Tumor Biol. 2015;36:2845–54.
Poirier F, Chan C, Timmons P, et al. The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development. 1991;113:1105–14.
Ariel L, Ayesh S, Periman EJ, et al. The product of the imprinted H19 gene is an oncofetal RNA. Mol Pathol. 1997;50(1):33–4.
Hibi K, Nakamura H, Hirai A, et al. Loss of H19 imprinting in esophageal cancer. Cancer Res. 1996;56:480–2.
Kondo M, Suzuki H, Ueda R, et al. Frequent loss of imprinting of the h19 gene is often associated with its overexpression in human lung cancers. Oncogene. 1995;10:1193–8.
Wang J, Song YX, Wang ZN. Non-coding RNAs in gastric cancer. Gene. 2015;560:1–8.
Zhang L, Yang F, Yuan JH, et al. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis. 2013;34:577–86.
Tsang WP, Ng EK, Ng SS, et al. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis. 2010;31:350–8.
Luo M, Li Z, Wang W, Zeng Y, et al. Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression. FEBS J. 2013;280:1709–16.
Ma C, Nong K, Zhu H, et al. H19 promotes pancreatic cancer metastasis by derepressing let-7’s suppression on its target HMGA2-mediated EMT. Tumor Biol. 2014;35:9163–9.
Barsyte-Lovejoy D, Lau SK, Boutros PC, et al. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res. 2006;66:5330–7.
Lottin S, Adriaenssens E, Dupressoir T, et al. Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis. 2002;23:1885–95.
Ayesh S, Matouk I, Schneider T, et al. Possible physiological role of H19 RNA. Mol Carcinog. 2002;35:63–74.
Matouk IJ, Mezan S, Mizrahi A, et al. The oncofetal H19 RNA connection: hypoxia, p53 and cancer. Biochim biophys Acta. 2010;1803:443–51.
Yang F, Bi J, Xue X, et al. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J. 2012;279:3159–65.
Zhang EB, Han L, Yin DD, et al. C-Myc-induced, long, non-coding H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer. Med Oncol. 2014;31:914.
Verhaegh GW, Verkleij L, Vermeulen SH, et al. Polymorphisms in the h19 gene and the risk of bladder cancer. Eur Urol. 2008;54:1118–26.
Gong W-J, Yin J-Y, Li X-P, et al. Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response. Tumor Biol. 2016;37:8349–58.
Riaz M, Berns EM, Sieuwerts AM, et al. Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes. Breast Cancer Res Treat. 2012;133(3):843–51.
Yang C, Tang R, Ma X, et al. Tag SNPs in long non-coding RNA H19 contribute to susceptibility to gastric cancer in the Chinese Han population. Oncotarget. 2015;6(17):15311–20.